Evaluating the effectiveness of tranexamic acid administration in reducing bleeding in benign prostate hyperplasia patients underwent open prostatectomy: A double-blind randomized clinical trial

BACKGROUND: Blood loss of postoperative after prostate surgery could be related with an increase in urinary fibrinolytic activity. Tranexamic acid (TXA) is both a potent inhibitor of plasminogen and urokinase activators and a low molecular weight substance that is excreted unchanged in the urinary t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadi Sichani, Mehrdad, Mohammadi, Sina, Khorrami, Mohammad Hatef, Zargham, Mahtab, Javid, Amir, Dehghani, Mehdi, Gholipour, Farshad, Dehkordi, Pardis Rafei, Kazemi, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039104/
https://www.ncbi.nlm.nih.gov/pubmed/36974110
http://dx.doi.org/10.4103/jrms.jrms_308_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039104/
https://www.ncbi.nlm.nih.gov/pubmed/36974110
http://dx.doi.org/10.4103/jrms.jrms_308_22

Ejemplares similares